Approximately 80% of psoriatic arthritis patients treated with Cosentyx® saw no progression of joint damage as shown in Novartis new two-year observational data

Approximately 80% of psoriatic arthritis patients treated with Cosentyx® saw no progression of joint damage as shown in Novartis new two-year observational data

Nov 07, 2015
Source URL: https://qa1.novartis.us/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0